The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

-Subsection 1

Name:	us-gaap_RecognitionOfDeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

License Agreements - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended	9 Months Ended	6 Months Ended
	Jan. 31, 2012 Daewoong Development And License Agreement [Member]	Mar. 31, 2012 Daewoong Development And License Agreement [Member]	Jun. 30, 2013 Pfizer License Agreement [Member]	Sep. 30, 2012 Pfizer License Agreement [Member]	Jun. 30, 2013 Actavis License And Commercialization Agreement [Member]	Jun. 30, 2012 Actavis License And Commercialization Agreement [Member]
Deferred Costs and Future Payment Commitment for Retail Supply Agreements [Line Items]
Revenue recognized under licensing agreement		$ 442,859
Term of the agreement	15 years
Period for receiving royalties			3 years
Recognition of deferred revenue				750,000
Revenue recognized					$ 1,099,116	$ 4,687,855